Peregrine Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.19M | Buy |
+702,711
| New | +$8.19M | 0.25% | 110 |
|
|
2024
Q2 | – | Sell |
-375,716
| Closed | -$1.21M | – | 326 |
|
|
2024
Q1 | $1.21M | Buy |
375,716
+78
| +0% | +$250 | 0.03% | 264 |
|
|
2023
Q4 | $1.84M | Sell |
375,638
-64,317
| -15% | -$315K | 0.06% | 245 |
|
|
2023
Q3 | $2.4M | Sell |
439,955
-27,331
| -6% | -$149K | 0.07% | 247 |
|
|
2023
Q2 | $3.14M | Sell |
467,286
-109
| -0% | -$731 | 0.09% | 247 |
|
|
2023
Q1 | $4.13M | Buy |
467,395
+199,764
| +75% | +$1.76M | 0.12% | 243 |
|
|
2022
Q4 | $2.05M | Sell |
267,631
-11,100
| -4% | -$84.8K | 0.06% | 241 |
|
|
2022
Q3 | $1.99M | Sell |
278,731
-15,222
| -5% | -$108K | 0.06% | 245 |
|
|
2022
Q2 | $2.38M | Sell |
293,953
-24,192
| -8% | -$196K | 0.07% | 252 |
|
|
2022
Q1 | $4.42M | Sell |
318,145
-21,316
| -6% | -$296K | 0.1% | 248 |
|
|
2021
Q4 | $9.53M | Buy |
339,461
+62,118
| +22% | +$1.74M | 0.19% | 209 |
|
|
2021
Q3 | $9.43M | Sell |
277,343
-44,578
| -14% | -$1.52M | 0.2% | 218 |
|
|
2021
Q2 | $13.2M | Buy |
321,921
+37,628
| +13% | +$1.54M | 0.24% | 200 |
|
|
2021
Q1 | $11.4M | Sell |
284,293
-12,513
| -4% | -$504K | 0.21% | 223 |
|
|
2020
Q4 | $17.6M | Sell |
296,806
-30,424
| -9% | -$1.8M | 0.33% | 108 |
|
|
2020
Q3 | $15.9M | Sell |
327,230
-45,817
| -12% | -$2.23M | 0.42% | 89 |
|
|
2020
Q2 | $18M | Sell |
373,047
-12,543
| -3% | -$607K | 0.51% | 68 |
|
|
2020
Q1 | $10.7M | Buy |
385,590
+90,041
| +30% | +$2.5M | 0.38% | 109 |
|
|
2019
Q4 | $8.84M | Buy |
+295,549
| New | +$8.84M | 0.23% | 158 |
|